Treatment with AMG 145.

2 trials

Sponsors

Amgen

Conditions

dyslipidemiahypercholesterolaemia

Phase 2

Multicenter, Controlled, Open-Label Extension (OLE) Study To Assess the Long-Term Safety and Efficacy of AMG 145 (study 20110110)

Active, not recruitingNL-OMON40037

Amgenhypercholesterolaemia

Start: 2012-01-19Target: 25Updated: 2024-05-06

Phase 3

A Multicenter, Controlled, Open-label Extension (OLE) Study to Assess the Long-term Safety and Efficacy of AMG 145

Active, not recruitingNL-OMON45229

Amgendyslipidemia

Start: 2013-08-15Target: 146Updated: 2024-04-29